Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2001 Jun;38(6):353–355. doi: 10.1136/jmg.38.6.353

The −48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Aβ load in brain

J Lambert 1, D Mann 1, J Harris 1, M Chartier-Harlin 1, A Cumming 1, J Coates 1, H Lemmon 1, D StClair 1, T Iwatsubo 1, C Lendon 1
PMCID: PMC1734889  PMID: 11389157

Abstract

Mutations in the presenilin 1 gene (PS1) account for the majority of early onset, familial, autosomal dominant forms of Alzheimer's disease (AD), whereas its role in other late onset forms of AD remains unclear. A −48 C/T polymorphism in the PS1 promoter has been associated with an increased genetic risk in early onset complex AD and moreover has been shown to influence the expression of the PS1 gene. This raises the possibility that previous conflicting findings from association studies with homozygosity for the PS1 intron 8 polymorphism might be the result of linkage disequilibrium with the -48 CC genotype. Here we provide further evidence of increased risk of AD associated with homozygosity for the −48 CC genotype (odds ratio=1.6). We also report a phenotypic correlation with Aβ40, Aβ42(43), and total Aβ load in AD brains. The −48 CC genotype was associated with 47% greater total Aβ load (p<0.003) compared to CT + TT genotype bearers. These results suggest that the -48 C/T polymorphism in the PS1 promoter may increase the risk of AD, perhaps by altering PS1 gene expression and thereby influencing Aβ load.


Keywords: Alzheimer; presenilin; promoter; polymorphism

Full Text

The Full Text of this article is available as a PDF (133.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bullido M. J., Artiga M. J., Recuero M., Sastre I., García M. A., Aldudo J., Lendon C., Han S. W., Morris J. C., Frank A. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet. 1998 Jan;18(1):69–71. doi: 10.1038/ng0198-69. [DOI] [PubMed] [Google Scholar]
  2. Cruts M., van Duijn C. M., Backhovens H., Van den Broeck M., Wehnert A., Serneels S., Sherrington R., Hutton M., Hardy J., St George-Hyslop P. H. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998 Jan;7(1):43–51. doi: 10.1093/hmg/7.1.43. [DOI] [PubMed] [Google Scholar]
  3. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998 Jan 22;391(6665):387–390. doi: 10.1038/34910. [DOI] [PubMed] [Google Scholar]
  4. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 1997 Apr;20(4):154–159. doi: 10.1016/s0166-2236(96)01030-2. [DOI] [PubMed] [Google Scholar]
  5. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994 Jul;13(1):45–53. doi: 10.1016/0896-6273(94)90458-8. [DOI] [PubMed] [Google Scholar]
  6. Lambert J. C., Berr C., Pasquier F., Delacourte A., Frigard B., Cottel D., Pérez-Tur J., Mouroux V., Mohr M., Cécyre D. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet. 1998 Sep;7(9):1511–1516. doi: 10.1093/hmg/7.9.1511. [DOI] [PubMed] [Google Scholar]
  7. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med. 1996 Oct;2(10):1146–1150. doi: 10.1038/nm1096-1146. [DOI] [PubMed] [Google Scholar]
  8. Lendon C. L., Ashall F., Goate A. M. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA. 1997 Mar 12;277(10):825–831. [PubMed] [Google Scholar]
  9. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 1997 Sep 5;90(5):917–927. doi: 10.1016/s0092-8674(00)80356-6. [DOI] [PubMed] [Google Scholar]
  10. Li Y. M., Xu M., Lai M. T., Huang Q., Castro J. L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J. G. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 2000 Jun 8;405(6787):689–694. doi: 10.1038/35015085. [DOI] [PubMed] [Google Scholar]
  11. Mann D. M., Pickering-Brown S. M., Bayatti N. N., Wright A. E., Owen F., Iwatsubo T., Saido T. C. An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid beta protein deposited in Alzheimer's disease. Neurosci Lett. 1997 Jan 24;222(1):57–60. doi: 10.1016/s0304-3940(97)13342-0. [DOI] [PubMed] [Google Scholar]
  12. Murayama O., Tomita T., Nihonmatsu N., Murayama M., Sun X., Honda T., Iwatsubo T., Takashima A. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci Lett. 1999 Apr 9;265(1):61–63. doi: 10.1016/s0304-3940(99)00187-1. [DOI] [PubMed] [Google Scholar]
  13. Naruse S., Thinakaran G., Luo J. J., Kusiak J. W., Tomita T., Iwatsubo T., Qian X., Ginty D. D., Price D. L., Borchelt D. R. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron. 1998 Nov;21(5):1213–1221. doi: 10.1016/s0896-6273(00)80637-6. [DOI] [PubMed] [Google Scholar]
  14. Theuns J., Del-Favero J., Dermaut B., van Duijn C. M., Backhovens H., Van den Broeck M. V., Serneels S., Corsmit E., Van Broeckhoven C. V., Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum Mol Genet. 2000 Feb 12;9(3):325–331. doi: 10.1093/hmg/9.3.325. [DOI] [PubMed] [Google Scholar]
  15. Theuns J., Van Broeckhoven C. Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum Mol Genet. 2000 Oct;9(16):2383–2394. doi: 10.1093/hmg/9.16.2383. [DOI] [PubMed] [Google Scholar]
  16. Wavrant-De Vrièze F., Crook R., Holmans P., Kehoe P., Owen M. J., Williams J., Roehl K., Laliiri D. K., Shears S., Booth J. Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late-onset Alzheimer's disease. Neurosci Lett. 1999 Jul 9;269(2):67–70. doi: 10.1016/s0304-3940(99)00417-6. [DOI] [PubMed] [Google Scholar]
  17. Wolozin B., Alexander P., Palacino J. Regulation of apoptosis by presenilin 1. Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S23–S27. doi: 10.1016/s0197-4580(98)00041-4. [DOI] [PubMed] [Google Scholar]
  18. Wragg M., Hutton M., Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet. 1996 Feb 24;347(9000):509–512. doi: 10.1016/s0140-6736(96)91140-x. [DOI] [PubMed] [Google Scholar]
  19. van Duijn C. M., Cruts M., Theuns J., Van Gassen G., Backhovens H., van den Broeck M., Wehnert A., Serneels S., Hofman A., Van Broeckhoven C. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample. Eur J Hum Genet. 1999 Oct-Nov;7(7):801–806. doi: 10.1038/sj.ejhg.5200373. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES